425 related articles for article (PubMed ID: 28474166)
21. Retrospective review of patients with atypical bisphosphonate related proximal femoral fractures.
Phillips HK; Harrison SJ; Akrawi H; Sidhom SA
Injury; 2017 Jun; 48(6):1159-1164. PubMed ID: 28410753
[TBL] [Abstract][Full Text] [Related]
22. Femoral insufficiency fractures with bisphosphonate therapy. Cases study.
Boszczyk A; Kowalski D; Zakrzewski P; Pomianowski S
Ortop Traumatol Rehabil; 2011; 13(4):403-8. PubMed ID: 21857071
[TBL] [Abstract][Full Text] [Related]
23. The advantages of tomosynthesis for evaluating bisphosphonate-related atypical femur fractures compared to radiography.
Petraszko A; Siegal D; Flynn M; Rao SD; Peterson E; van Holsbeeck M
Skeletal Radiol; 2016 May; 45(5):615-23. PubMed ID: 26861160
[TBL] [Abstract][Full Text] [Related]
24. High and pointed type of femoral localized reaction frequently extends to complete and incomplete atypical femoral fracture in patients with autoimmune diseases on long-term glucocorticoids and bisphosphonates.
Sato H; Kondo N; Nakatsue T; Wada Y; Fujisawa J; Kazama JJ; Kuroda T; Suzuki Y; Nakano M; Endo N; Narita I
Osteoporos Int; 2017 Aug; 28(8):2367-2376. PubMed ID: 28409215
[TBL] [Abstract][Full Text] [Related]
25. Femoral insufficiency fractures associated with prolonged bisphosphonate therapy.
Isaacs JD; Shidiak L; Harris IA; Szomor ZL
Clin Orthop Relat Res; 2010 Dec; 468(12):3384-92. PubMed ID: 20809164
[TBL] [Abstract][Full Text] [Related]
26. Nonoperative versus prophylactic treatment of bisphosphonate-associated femoral stress fractures.
Banffy MB; Vrahas MS; Ready JE; Abraham JA
Clin Orthop Relat Res; 2011 Jul; 469(7):2028-34. PubMed ID: 21350886
[TBL] [Abstract][Full Text] [Related]
27. Obliteration of the medullary canal in an atypical bisphosphonate-related femoral fracture.
Cawley DT; Barrett HL; Harrington P
BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25568263
[TBL] [Abstract][Full Text] [Related]
28. The outcome of surgically treated femur fractures associated with long-term bisphosphonate use.
Weil YA; Rivkin G; Safran O; Liebergall M; Foldes AJ
J Trauma; 2011 Jul; 71(1):186-90. PubMed ID: 21610533
[TBL] [Abstract][Full Text] [Related]
29. Alendronate-associated femoral insufficiency fractures and femoral stress reactions.
Wang K; Moaveni A; Dowrick A; Liew S
J Orthop Surg (Hong Kong); 2011 Apr; 19(1):89-92. PubMed ID: 21519086
[TBL] [Abstract][Full Text] [Related]
30. Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide.
Miyakoshi N; Aizawa T; Sasaki S; Ando S; Maekawa S; Aonuma H; Tsuchie H; Sasaki H; Kasukawa Y; Shimada Y
J Bone Miner Metab; 2015 Sep; 33(5):553-9. PubMed ID: 25227287
[TBL] [Abstract][Full Text] [Related]
31. Rare non-traumatic periprosthetic femoral fracture with features of an atypical femoral fracture: a case report.
Niikura T; Lee SY; Sakai Y; Kuroda R; Kurosaka M
J Med Case Rep; 2015 May; 9():103. PubMed ID: 25943378
[TBL] [Abstract][Full Text] [Related]
32. Frequency of incomplete atypical femoral fractures in asymptomatic patients on long-term bisphosphonate therapy.
La Rocca Vieira R; Rosenberg ZS; Allison MB; Im SA; Babb J; Peck V
AJR Am J Roentgenol; 2012 May; 198(5):1144-51. PubMed ID: 22528906
[TBL] [Abstract][Full Text] [Related]
33. [Atypical femoral fracture associated with the use of bisphosphonates, an adverse drug reaction not to be missed].
Ing Lorenzinit K; Meier R; Suva D; Dayer P; Desmeules J; Peter R
Rev Med Suisse; 2012 Jun; 8(344):1238-42. PubMed ID: 22730621
[TBL] [Abstract][Full Text] [Related]
34. Bisphosphonates and their influence on fracture healing: a systematic review.
Molvik H; Khan W
Osteoporos Int; 2015 Apr; 26(4):1251-60. PubMed ID: 25572046
[TBL] [Abstract][Full Text] [Related]
35. Teriparatide improves bone quality and healing of atypical femoral fractures associated with bisphosphonate therapy.
Chiang CY; Zebaze RM; Ghasem-Zadeh A; Iuliano-Burns S; Hardidge A; Seeman E
Bone; 2013 Jan; 52(1):360-5. PubMed ID: 23072919
[TBL] [Abstract][Full Text] [Related]
36. Sequential subtrochanteric femoral fracture after atypical diaphyseal fracture in a long-term bisphosphonate user: a case report.
Park KT; Lee KB
Acta Chir Orthop Traumatol Cech; 2015; 82(2):157-60. PubMed ID: 26317188
[TBL] [Abstract][Full Text] [Related]
37. Strains caused by daily loading might be responsible for delayed healing of an incomplete atypical femoral fracture.
Gustafsson A; Schilcher J; Grassi L; Aspenberg P; Isaksson H
Bone; 2016 Jul; 88():125-130. PubMed ID: 27113528
[TBL] [Abstract][Full Text] [Related]
38. Association of atypical femoral fractures with bisphosphonate use by patients with varus hip geometry.
Hagen JE; Miller AN; Ott SM; Gardner M; Morshed S; Jeray K; Alton TB; Ren D; Abblitt WP; Krieg JC
J Bone Joint Surg Am; 2014 Nov; 96(22):1905-9. PubMed ID: 25410509
[TBL] [Abstract][Full Text] [Related]
39. Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur.
Greenspan SL; Vujevich K; Britton C; Herradura A; Gruen G; Tarkin I; Siska P; Hamlin B; Perera S
Osteoporos Int; 2018 Feb; 29(2):501-506. PubMed ID: 29085957
[TBL] [Abstract][Full Text] [Related]
40. Atypical bilateral femoral shaft fracture in patient treated with bisphosphonates.
Parrón Cambero R; Rey López A; Tomé-Bermejo F; Cibantos Martínez R
Eur J Orthop Surg Traumatol; 2013 Nov; 23 Suppl 2():S219-23. PubMed ID: 23412218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
